AMYGDALA-KINDLING AS A MODEL FOR CHRONIC EFFICACY STUDIES ON ANTIEPILEPTIC DRUGS - EXPERIMENTS WITH CARBAMAZEPINE

被引:42
作者
HONACK, D
LOSCHER, W
机构
[1] SCH VET MED,DEPT PHARMACOL TOXICOL & PHARM,BUNTEWEG 17,D-3000 HANNOVER 71,FED REP GER
[2] FREE UNIV BERLIN,SCH VET MED,DEPT PHARMACOL & TOXICOL,D-1000 BERLIN 33,FED REP GER
关键词
D O I
10.1016/0028-3908(89)90139-1
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
引用
收藏
页码:599 / 610
页数:12
相关论文
共 21 条
[1]   CARBAMAZEPINE - A PHARMACOLOGICAL STUDY IN THE KINDLING MODEL OF EPILEPSY [J].
ALBERTSON, TE ;
JOY, RM ;
STARK, LG .
NEUROPHARMACOLOGY, 1984, 23 (10) :1117-1123
[2]   DEVELOPMENT OF A NEW PHARMACOLOGICAL SEIZURE MODEL - EFFECTS OF ANTICONVULSANTS ON CORTICAL-KINDLED AND AMYGDALA-KINDLED SEIZURES IN THE RAT [J].
ALBRIGHT, PS ;
BURNHAM, WM .
EPILEPSIA, 1980, 21 (06) :681-689
[3]   PLASMA KINETICS OF CARBAMAZEPINE AND ITS EPOXIDE METABOLITE IN MAN AFTER SINGLE AND MULTIPLE DOSES [J].
EICHELBAUM, M ;
EKBOM, K ;
BERTILSSON, L ;
RINGBERGER, VA ;
RANE, A .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1975, 8 (05) :337-341
[4]  
FARGHALIHASSAN, 1976, ARCH INT PHARMACOD T, V220, P125
[5]   ANTICONVULSANT EFFECT OF PRIMIDONE IN THE GERBIL - TIME COURSE AND SIGNIFICANCE OF THE ACTIVE METABOLITES [J].
FREY, HH ;
LOSCHER, W ;
REICHE, R ;
SCHULTZ, D .
PHARMACOLOGY, 1984, 28 (06) :329-335
[6]  
FREY HH, 1980, ARCH INT PHARMACOD T, V243, P180
[7]  
FREY HH, 1986, TOLERANCE BENEFICIAL, P7
[8]  
FREY HH, 1985, HDB EXPT PHARM, V74, P266
[9]  
HVIDBERG EF, 1985, HDB EXPT PHARM, V74, P725
[10]  
KOELLA WP, 1986, TOLERANCE BENEFICIAL, P81